BDBM437083 2-[6-(4-Fuoro-3-methyl-phenyl)-3-methyl-2-oxo-imidazo[4,5-b]pyridin-1-yl]- N,N-dimethyl-acetamide::US10617676, Example 420::US11207298, Example 420

SMILES CN(C)C(=O)Cn1c2cc(cnc2n(C)c1=O)-c1ccc(F)c(C)c1

InChI Key InChIKey=IJRVELKVEKRDRM-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 437083   

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM437083(US10617676, Example 420 | 2-[6-(4-Fuoro-3-methyl-p...)
Affinity DataIC50: 17nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2020
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM437083(US10617676, Example 420 | 2-[6-(4-Fuoro-3-methyl-p...)
Affinity DataIC50: 17nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
Go to US Patent